Your session is about to expire
← Back to Search
Focused Ultrasound
Transcranial ExABlate for Brain Tumor
N/A
Waitlist Available
Research Sponsored by InSightec
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at the time of exablate transcranial procedure
Awards & highlights
Study Summary
This trial is testing if it is safe to increase the amount of a chemotherapy drug that enters the brain by using ultrasound waves to open the blood-brain-barrier for a short period of time.
Eligible Conditions
- Brain Tumor
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ at the time of exablate transcranial procedure
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at the time of exablate transcranial procedure
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Number of Device and Procedure related adverse events
Secondary outcome measures
Severity of Device and Procedure related adverse events
Trial Design
1Treatment groups
Experimental Treatment
Group I: Transcranial ExAblateExperimental Treatment1 Intervention
MR Guided Focused Ultrasound
Find a Location
Who is running the clinical trial?
InSightecLead Sponsor
89 Previous Clinical Trials
3,704 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger